Skip to main content
. 2021 May 19;321(2):G99–G112. doi: 10.1152/ajpgi.00106.2021

Figure 5.

Figure 5.

Evidence for active and prolonged “quiescent” GI infection even in the absence of GI manifestations and after recovery from respiratory infection of SARS-CoV-2. Gut microbiota of patients with active SARS-CoV-2 GI infection was characterized by enrichment of opportunistic pathogens, loss of salutary bacteria, and increased functional capacity for nucleotide and amino acid biosynthesis and carbohydrate metabolism. GI, gastrointestinal. Created with Servier Medical Art.